On October 5, 2009
Talecris IPO Gives Cerberus Much-Needed Happy Ending
The $950 million initial public offering priced by Talecris Biotherapeutics last week was good for a lot of people — perhaps none more than private equity firm Cerberus Partners, which was desperately in need of a happy ending.
0 Comments